Healthcare Value Capital as of Dec. 31, 2013
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 33 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P MidCap 400 ETF (MDY) | 12.5 | $17M | 70k | 244.20 | |
| iShares NASDAQ Biotechnology Index (IBB) | 12.5 | $17M | 75k | 227.07 | |
| Teva Pharmaceutical Industries (TEVA) | 7.5 | $10M | 255k | 40.07 | |
| Biosante Pharmaceuticals (ANIP) | 7.2 | $9.7M | 485k | 20.08 | |
| Spdr S&p 500 Etf (SPY) | 6.8 | $9.2M | 50k | 184.70 | |
| Supernus Pharmaceuticals (SUPN) | 6.4 | $8.7M | 1.2M | 7.54 | |
| Auxilium Pharmaceuticals | 5.1 | $6.9M | 335k | 20.73 | |
| Pfizer (PFE) | 4.5 | $6.1M | 200k | 30.63 | |
| iShares Russell 2000 Index (IWM) | 4.2 | $5.8M | 50k | 115.36 | |
| AstraZeneca (AZN) | 3.6 | $4.9M | 82k | 59.38 | |
| Health Net | 3.3 | $4.5M | 150k | 29.68 | |
| Forest Laboratories | 3.1 | $4.2M | 70k | 60.03 | |
| Quest Diagnostics Incorporated (DGX) | 3.0 | $4.1M | 77k | 53.54 | |
| Merck & Co (MRK) | 2.8 | $3.9M | 77k | 50.05 | |
| Endo Pharmaceuticals | 2.5 | $3.4M | 50k | 67.46 | |
| Given Imaging | 2.2 | $3.0M | 100k | 30.08 | |
| Qlt | 2.1 | $2.9M | 527k | 5.57 | |
| GlaxoSmithKline | 1.8 | $2.5M | 46k | 53.39 | |
| Sanofi-Aventis SA (SNY) | 1.3 | $1.8M | 33k | 53.64 | |
| Sagent Pharmaceuticals | 1.1 | $1.5M | 59k | 25.37 | |
| Baxter International (BAX) | 1.0 | $1.4M | 20k | 69.55 | |
| Proshares Ultrashort Russell 2000 | 0.9 | $1.2M | 100k | 12.03 | |
| CryoLife (AORT) | 0.8 | $1.1M | 100k | 11.09 | |
| Biota Pharmaceuticals | 0.6 | $857k | 205k | 4.19 | |
| Zogenix | 0.5 | $607k | 176k | 3.44 | |
| Amicus Therapeutics (FOLD) | 0.4 | $588k | 250k | 2.35 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $570k | 200k | 2.85 | |
| Kindred Biosciences | 0.4 | $559k | 50k | 11.18 | |
| Cornerstone Therapeutics | 0.3 | $475k | 50k | 9.50 | |
| XenoPort | 0.3 | $443k | 77k | 5.75 | |
| Sunesis Pharmaceuticals | 0.3 | $394k | 83k | 4.74 | |
| Cytokinetics (CYTK) | 0.3 | $368k | 57k | 6.49 | |
| D Stemline Therapeutics | 0.2 | $323k | 17k | 19.62 |
